237 related articles for article (PubMed ID: 25149976)
1. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases.
Sobczak M; Zakrzewski PK; Cygankiewicz AI; Mokrowiecka A; Chen C; Sałaga M; Małecka-Panas E; Kordek R; Krajewska WM; Fichna J
Pharmacol Rep; 2014 Oct; 66(5):741-50. PubMed ID: 25149976
[TBL] [Abstract][Full Text] [Related]
2. Novel orally available salvinorin A analog PR-38 protects against experimental colitis and reduces abdominal pain in mice by interaction with opioid and cannabinoid receptors.
Sałaga M; Polepally PR; Zakrzewski PK; Cygankiewicz A; Sobczak M; Kordek R; Zjawiony JK; Krajewska WM; Fichna J
Biochem Pharmacol; 2014 Dec; 92(4):618-26. PubMed ID: 25265540
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory and antinociceptive action of an orally available nociceptin receptor agonist SCH 221510 in a mouse model of inflammatory bowel diseases.
Sobczak M; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Storr M; Kordek R; Małecka-Panas E; Krajewska WM; Fichna J
J Pharmacol Exp Ther; 2014 Mar; 348(3):401-9. PubMed ID: 24345466
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of anti-inflammatory effect of silver-coated glass beads in mice with experimentally induced colitis as a new type of treatment in inflammatory bowel disease.
Siczek K; Zatorski H; Chmielowiec-Korzeniowska A; Kordek R; Tymczyna L; Fichna J
Pharmacol Rep; 2017 Jun; 69(3):386-392. PubMed ID: 28267639
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory and antinociceptive action of the dimeric enkephalin peptide biphalin in the mouse model of colitis: new potential treatment of abdominal pain associated with inflammatory bowel diseases.
Sobczak M; Pilarczyk A; Jonakowski M; Jarmuż A; Sałaga M; Lipkowski AW; Fichna J
Peptides; 2014 Oct; 60():102-6. PubMed ID: 25151037
[TBL] [Abstract][Full Text] [Related]
6. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
Tang R; Yang G; Zhang S; Wu C; Chen M
Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
[TBL] [Abstract][Full Text] [Related]
7. Salvinorin A has antiinflammatory and antinociceptive effects in experimental models of colitis in mice mediated by KOR and CB1 receptors.
Fichna J; Dicay M; Lewellyn K; Janecka A; Zjawiony JK; MacNaughton WK; Storr MA
Inflamm Bowel Dis; 2012 Jun; 18(6):1137-45. PubMed ID: 21953882
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of dextran sulfate sodium-induced colitis by anti-macrophage migration inhibitory factor antibody in mice.
Ohkawara T; Nishihira J; Takeda H; Hige S; Kato M; Sugiyama T; Iwanaga T; Nakamura H; Mizue Y; Asaka M
Gastroenterology; 2002 Jul; 123(1):256-70. PubMed ID: 12105854
[TBL] [Abstract][Full Text] [Related]
10. Recombinant adeno-associated virus carrying thymosin β
Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
[TBL] [Abstract][Full Text] [Related]
11. Orally administered novel cyclic pentapeptide P-317 alleviates symptoms of diarrhoea-predominant irritable bowel syndrome.
Zielińska M; Chen C; Mokrowiecka A; Cygankiewicz AI; Zakrzewski PK; Sałaga M; Małecka-Panas E; Wlaź P; Krajewska WM; Fichna J
J Pharm Pharmacol; 2015 Feb; 67(2):244-54. PubMed ID: 25515402
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of galangin against dextran sulfate sodium (DSS)-induced ulcerative colitis in Balb/c mice.
Sangaraju R; Nalban N; Alavala S; Rajendran V; Jerald MK; Sistla R
Inflamm Res; 2019 Aug; 68(8):691-704. PubMed ID: 31147743
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory effect of dual nociceptin and opioid receptor agonist, BU08070, in experimental colitis in mice.
Zielińska M; Ben Haddou T; Cami-Kobeci G; Sałaga M; Jarmuż A; Padysz M; Kordek R; Spetea M; Husbands SM; Fichna J
Eur J Pharmacol; 2015 Oct; 765():582-90. PubMed ID: 26404500
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory and anti-apoptotic effects of rosuvastatin by regulation of oxidative stress in a dextran sulfate sodium-induced colitis model.
Shin SK; Cho JH; Kim EJ; Kim EK; Park DK; Kwon KA; Chung JW; Kim KO; Kim YJ
World J Gastroenterol; 2017 Jul; 23(25):4559-4568. PubMed ID: 28740344
[TBL] [Abstract][Full Text] [Related]
15. Sanhuang Shu'ai decoction alleviates DSS-induced ulcerative colitis via regulation of gut microbiota, inflammatory mediators and cytokines.
Wu ZC; Zhao ZL; Deng JP; Huang JT; Wang YF; Wang ZP
Biomed Pharmacother; 2020 May; 125():109934. PubMed ID: 32058214
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease.
de Bruyn M; Breynaert C; Arijs I; De Hertogh G; Geboes K; Thijs G; Matteoli G; Hu J; Van Damme J; Arnold B; Ferrante M; Vermeire S; Van Assche G; Opdenakker G
Nat Commun; 2017 May; 8():15384. PubMed ID: 28561062
[TBL] [Abstract][Full Text] [Related]
17. Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice.
Sudirman S; Hsu YH; He JL; Kong ZL
PLoS One; 2018; 13(10):e0205252. PubMed ID: 30289911
[TBL] [Abstract][Full Text] [Related]
18. Intestinal anti-inflammatory activity of the seeds of Raphanus sativus L. in experimental ulcerative colitis models.
Choi KC; Cho SW; Kook SH; Chun SR; Bhattarai G; Poudel SB; Kim MK; Lee KY; Lee JC
J Ethnopharmacol; 2016 Feb; 179():55-65. PubMed ID: 26721217
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
